Redor Pathways Regulating Nemeprotein Maturation in Asthma

Redor 通路调节哮喘中的 Neme 蛋白成熟

基本信息

  • 批准号:
    9232190
  • 负责人:
  • 金额:
    $ 31.39万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-04-15 至
  • 项目状态:
    未结题

项目摘要

ABSTRACT - PROJECT 3 Metalloproteins that contain a heme prosthetic group (hemeproteins) are essential to lung functions, including airway host defense and inflammation [inducible nitric oxide (NO) synthase (iNOS)], and bronchomotor tone [soluble guanylate cyclase (sGC)]. We recently discovered that NO inhibits heme insertion into apo-proteins by the S-nitrosyation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which functions in heme transport and insertion. Recycling GAPDH is dependent on cellular redox and S-denitrosylase enzymes, i.e. GSNO reductase (GSNOR) or thioredoxin 1 (Trx1). These exciting findings and longstanding interactions with Program members in the study of asthma over the years made it a natural step to investigate whether the high- levels of NO in the asthmatic airway blocks hemeprotein maturation. Our preliminary results show that asthmatic airway epithelium escapes NO-mediated inhibition of heme insertion by upregulation of denitrosylase pathways, enabling the expression of active iNOS, but that airway smooth muscle cells are overwhelmed by NO at the levels produced in the asthmatic airway, with consequent loss of heme-replete sGC. New preliminary data generated in murine models of asthma and in the human precision cut lung slice model suggest that heme-independent sGC-activators are strikingly effective bronchodilators. Thus, we will test the hypothesis that thiol denitrosylase systems enable continuous airway epithelial NO production by iNOS in asthma by restoration of hemeprotein maturation, but that the NO overwhelms smooth muscle denitrosylase systems, compromising maturation & function of the sGC in smooth muscle, which results in bronchoconstriction and airway hyper-reactivity. We plan concurrent mechanistic studies and studies of the bronchodilator response to novel pharmacologic sGC agonists in (i) primary airway smooth muscle cells from healthy and asthmatic airways, (ii) precision cut human lung slice model and (iii) mouse models of asthma using genetically modified mice (including NOS1,2,&3 -/-, GSNOR-/- and smooth muscle specific sGC-/-). Also, we will study hemeprotein maturation in airway epithelial cells freshly obtained from healthy individuals and asthmatics with low or high FENO to help verify clinical relevance and potentially endotype sGC-agonist responders. sGC agonists will be tested in order to translate the discoveries to patient care soon. This research will provide the first information on hemeprotein maturation in healthy and asthmatic airway, and test connections between dysregulation of hemeprotein maturation and the bronchoconstriction and inflammation characteristic of asthma.
摘要--项目3 含有血红素修复基团的金属蛋白(血红素蛋白)对肺功能是必不可少的,包括 呼吸道宿主防御和炎症[诱导型一氧化氮合酶(INOS)]和支气管运动张力 [可溶性鸟苷环化酶(SGC)]。我们最近发现,NO通过以下途径抑制血红素插入载脂蛋白 参与血红素转运的甘油醛-3-磷酸脱氢酶的S亚硝化 和插入物。GAPDH的循环依赖于细胞内的氧化还原和S脱氮酶,即GSNO 还原酶(GSNOR)或硫氧还蛋白1(Trx1)。这些令人兴奋的发现和长期的互动 多年来从事哮喘研究的项目成员自然而然地调查了高水平的 哮喘呼吸道中的NO水平阻碍了血红蛋白的成熟。我们的初步结果显示, 哮喘气道上皮通过上调脱氮酶逃脱NO介导的血红素插入抑制 途径,使活跃的iNOS表达,但气道平滑肌细胞被 NO在哮喘呼吸道中产生的水平,从而导致富含血红素的sGC的损失。新的 在小鼠哮喘模型和人类精密切片肺切片模型中产生的初步数据 表明不依赖于血红素的sGC激活剂是非常有效的支气管扩张剂。因此,我们将测试 硫醇脱氮酶系统可持续诱导大鼠气道上皮细胞产生NO的假说 哮喘通过恢复血红蛋白成熟,但NO压倒了平滑肌脱氮酶 系统,损害SGC在平滑肌中的成熟和功能,从而导致 支气管收缩和呼吸道高反应性。我们计划同时进行机械学研究和对 支气管扩张剂对新型药物sGC激动剂的作用(I)原代培养的气道平滑肌细胞 健康和哮喘的呼吸道,(Ii)精确切割的人肺切片模型和(Iii)哮喘的小鼠模型 使用转基因小鼠(包括NOS1、2和3-/-、GSNOR-/-和平滑肌特异性sGC-/-)。另外, 我们将研究新鲜从健康个体获得的呼吸道上皮细胞中的血红蛋白成熟情况。 低FeNO或高FeNO哮喘患者有助于验证临床相关性和潜在的内型sGC激动剂 响应者。SGC激动剂将进行测试,以便很快将发现转化为患者护理。这 研究将提供关于健康和哮喘呼吸道中的血红蛋白成熟的第一个信息,并进行测试 血红蛋白成熟失调与支气管收缩和炎症的关系 以哮喘为特征的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENNIS J STUEHR其他文献

DENNIS J STUEHR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENNIS J STUEHR', 18)}}的其他基金

Defining a pathway for mitochondrial heme trafficking
定义线粒体血红素运输途径
  • 批准号:
    10733705
  • 财政年份:
    2023
  • 资助金额:
    $ 31.39万
  • 项目类别:
Coordinate control of hemeprotein maturation and function by cell chaperones, heme, and nitric oxide
细胞伴侣、血红素和一氧化氮协调控制血红素蛋白的成熟和功能
  • 批准号:
    10207671
  • 财政年份:
    2019
  • 资助金额:
    $ 31.39万
  • 项目类别:
Coordinate control of hemeprotein maturation and function by cell chaperones, heme, and nitric oxide
细胞伴侣、血红素和一氧化氮协调控制血红素蛋白的成熟和功能
  • 批准号:
    10428556
  • 财政年份:
    2019
  • 资助金额:
    $ 31.39万
  • 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
  • 批准号:
    8241962
  • 财政年份:
    2011
  • 资助金额:
    $ 31.39万
  • 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
  • 批准号:
    8636030
  • 财政年份:
    2011
  • 资助金额:
    $ 31.39万
  • 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
  • 批准号:
    8449268
  • 财政年份:
    2011
  • 资助金额:
    $ 31.39万
  • 项目类别:
New mechanism and regulation of intracellular heme delivery in mammals
哺乳动物细胞内血红素输送的新机制和调控
  • 批准号:
    8082579
  • 财政年份:
    2011
  • 资助金额:
    $ 31.39万
  • 项目类别:
2009 Nitric Oxide Gordon Research Conference
2009 年一氧化氮戈登研究会议
  • 批准号:
    7600784
  • 财政年份:
    2009
  • 资助金额:
    $ 31.39万
  • 项目类别:
Nitric Oxide Synthases As Oxidative And Therapeutic Agents
作为氧化剂和治疗剂的一氧化氮合成酶
  • 批准号:
    7664775
  • 财政年份:
    2008
  • 资助金额:
    $ 31.39万
  • 项目类别:
Redor Pathways Regulating Nemeprotein Maturation in Asthma
Redor 通路调节哮喘中的 Neme 蛋白成熟
  • 批准号:
    9015473
  • 财政年份:
    2006
  • 资助金额:
    $ 31.39万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了